Found 12 matching trials
PVSRIPO for Patients With Unresectable Melanoma
PHASE1This study is a Phase I study of oncolytic polio/rhinovirus recombinant (PV...
Location
Duke University Medical Center
Lerapolturev in Recurrent Malignant Glioma
PHASE2This is a phase 2 study of lerapolturev, an oncolytic polio/rhinovirus reco...
Location
UCSF Neurological Surgery
PVSRIPO in Combination With Nivolumab in Melanoma
PHASE1In this study, patients with metastatic melanoma who have at least one inje...
Location
Duke University Medical Center
EAP for the Treatment of Glioblastoma With PVSRIPO
N/AThis is an open-label, single-arm, non-randomized, intermediate-sized expan...
Status
No Longer Available
Location
Duke University Medical Center
LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma
PHASE2This Phase 2 single arm trial in patients with rGBM will characterize the e...
Location
University of California San Francisco
LUMINOS-103: A Basket Trial of Safety & Efficacy of Lerapolturev With or Without Checkpoint Inhibitors
PHASE1This is a Phase 1/2, open-label, multi-center, single arm basket study eval...
Location
Carolina Urologic Research Center
Lerapolturev (PVSRIPO) in GBM
PHASE2The purpose of this research study is to determine the safety and efficacy ...
Location
Duke University Medical Center
Examining Bioactivity of PVSRIPO in Invasive Breast Cancer
EARLY_PHASE1This is a pilot study to examine PVSRIPO bioactivity in tumor tissue after ...
Location
Duke University Medical Center
PVSRIPO for Recurrent Glioblastoma (GBM)
PHASE1Purpose of the Study:
To determine the maximally tolerated dose (MTD) and ...
Location
Duke University Medical Center
Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma
PHASE1This study evaluates the safety of PVSRIPO treatment in combination with At...
Location
Multiple Locations